133 related articles for article (PubMed ID: 7908608)
1. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer.
Weston A; Ling-Cawley HM; Caporaso NE; Bowman ED; Hoover RN; Trump BF; Harris CC
Carcinogenesis; 1994 Apr; 15(4):583-7. PubMed ID: 7908608
[TBL] [Abstract][Full Text] [Related]
2. Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.
Weston A; Caporaso NE; Perrin LS; Sugimura H; Tamai S; Krontiris TG; Trump BF; Hoover RN; Harris CC
Environ Health Perspect; 1992 Nov; 98():61-7. PubMed ID: 1486864
[TBL] [Abstract][Full Text] [Related]
3. Allelic frequency of a p53 polymorphism in human lung cancer.
Weston A; Perrin LS; Forrester K; Hoover RN; Trump BF; Harris CC; Caporaso NE
Cancer Epidemiol Biomarkers Prev; 1992; 1(6):481-3. PubMed ID: 1302561
[TBL] [Abstract][Full Text] [Related]
4. Restriction fragment length polymorphism analysis of the L-myc gene locus in a case-control study of lung cancer.
Tamai S; Sugimura H; Caporaso NE; Resau JH; Trump BF; Weston A; Harris CC
Int J Cancer; 1990 Sep; 46(3):411-5. PubMed ID: 1975565
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Cooper J; Carpenter CL; Navidi WC; Ding L; Idle JR
Pharmacogenetics; 1996 Apr; 6(2):151-8. PubMed ID: 9156693
[TBL] [Abstract][Full Text] [Related]
6. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.
Kato S; Shields PG; Caporaso NE; Sugimura H; Trivers GE; Tucker MA; Trump BF; Weston A; Harris CC
Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):515-8. PubMed ID: 8000304
[TBL] [Abstract][Full Text] [Related]
7. Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases.
Shih CM; Kuo YY; Wang YC; Jian SL; Hsu YT; Wu HY; Guo MW; Wang YC
Lung Cancer; 2002 May; 36(2):125-32. PubMed ID: 11955646
[TBL] [Abstract][Full Text] [Related]
8. Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese.
Stephens EA; Taylor JA; Kaplan N; Yang CH; Hsieh LL; Lucier GW; Bell DA
Pharmacogenetics; 1994 Aug; 4(4):185-92. PubMed ID: 7987402
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer, race, and a CYP1A1 genetic polymorphism.
Shields PG; Caporaso NE; Falk RT; Sugimura H; Trivers GE; Trump BF; Hoover RN; Weston A; Harris CC
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):481-5. PubMed ID: 8220094
[TBL] [Abstract][Full Text] [Related]
10. Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer?
Yaylim I; Isbir T; Oztürk O; Turna A; Işitmangil T; Zonüzi F; Camlica H
Cancer Genet Cytogenet; 2002 Apr; 134(2):118-22. PubMed ID: 12034523
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.
Weston A; Godbold JH
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):919-26. PubMed ID: 9255581
[TBL] [Abstract][Full Text] [Related]
12. P53 polymorphisms and haplotypes in lung cancer.
Birgander R; Själander A; Rannug A; Alexandrie AK; Sundberg MI; Seidegård J; Tornling G; Beckman G; Beckman L
Carcinogenesis; 1995 Sep; 16(9):2233-6. PubMed ID: 7554081
[TBL] [Abstract][Full Text] [Related]
13. DNA polymorphisms of apolipoprotein B in the population of Senegal.
Chauffert M; Larghero J; Ngohou-Botum K; Cisse A; Chevenne D; Trivin F
Ann Hum Genet; 1997 Nov; 61(Pt 6):525-9. PubMed ID: 9543553
[TBL] [Abstract][Full Text] [Related]
14. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity.
Wu X; Zhao H; Amos CI; Shete S; Makan N; Hong WK; Kadlubar FF; Spitz MR
J Natl Cancer Inst; 2002 May; 94(9):681-90. PubMed ID: 11983757
[TBL] [Abstract][Full Text] [Related]
15. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype.
Jin X; Wu X; Roth JA; Amos CI; King TM; Branch C; Honn SE; Spitz MR
Carcinogenesis; 1995 Sep; 16(9):2205-8. PubMed ID: 7554076
[TBL] [Abstract][Full Text] [Related]
16. Functional studies of a germ-line polymorphism at codon 47 within the p53 gene.
Felley-Bosco E; Weston A; Cawley HM; Bennett WP; Harris CC
Am J Hum Genet; 1993 Sep; 53(3):752-9. PubMed ID: 8352280
[TBL] [Abstract][Full Text] [Related]
17. Close correlation between restriction fragment length polymorphism of L-myc gene and susceptibility to gastric cancer.
Isbir T; Yaylim I; Arikan S; Kaytan E; Karşidağ T; Bayrak S; Camlica H
Cancer Detect Prev; 2002; 26(6):454-7. PubMed ID: 12507230
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California.
London SJ; Daly AK; Leathart JB; Navidi WC; Idle JR
Pharmacogenetics; 1996 Dec; 6(6):527-33. PubMed ID: 9014202
[TBL] [Abstract][Full Text] [Related]
19. Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53.
Irarrázabal CE; Rojas C; Aracena R; Márquez C; Gil L
Toxicol Lett; 2003 Sep; 144(1):69-76. PubMed ID: 12919725
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between scleroderma and types I and III procollagen gene restriction fragment length polymorphisms.
Kratz LE; Boughman JA; Needleman BW
Arthritis Rheum; 1989 Dec; 32(12):1597-600. PubMed ID: 2574578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]